Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Gastrointestinal 1Classical hematology 1

Conditions

Colorectal Neoplasms 1

Interventions

Specimen Handling 82Fluorouracil 77Oxaliplatin 71Magnetic Resonance Spectroscopy 61Leucovorin 59Bevacizumab 54Gemcitabine 52Capecitabine 43Biopsy 41Irinotecan 36Cisplatin 36Nivolumab 35pembrolizumab 33durvalumab 31Cetuximab 30Paclitaxel 27130-nm albumin-bound paclitaxel 25atezolizumab 19Folfox protocol 19dehydroftorafur 18Radiotherapy 18Carboplatin 17Taxes 16X-Rays 14Radiation 14Cyclophosphamide 14trastuzumab deruxtecan 12fludarabine 12Surgical Procedures, Operative 12Albumin-Bound Paclitaxel 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metronidazole × Gastrointestinal × 30 days × Clear all
NCT06728072 2026-05-06

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Virginia Commonwealth University

Phase 2 Recruiting
97 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡